The Effect of Complex Decongestive Therapy in Patients With Lymphedema
NCT ID: NCT06220903
Last Updated: 2024-01-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2018-09-01
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Metabolic Syndrome on Complex Decongestive Physiotherapy Outcomes in Lymphedema Patients
NCT05426993
The Effect of LymphaTouch® and Manual Lymphatic Drainage on Extremity Circumference Measurements in Lymphedema
NCT07240324
The Effect of Manual Lymph Drainage Applied As an Adjunct to Compression Therapy on Edema Lower Extremity Lymphedema:
NCT06750679
Effectiveness of Digital Physiotherapy in the Short and Long-Term Management of Lower Extremity Lymphedema
NCT07014566
Complex Decongestive Physiotherapy Applied After Lymphovenous Anastomosis Surgery
NCT06167993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Complex Decongestive Physiotherapy is proven effective and considered the gold standard for the treatment of lymphedema. It increases the hydrostatic pressure that has decreased due to edema and helps the lymph fluid to re-enter the circulation.
Purpose of the study; To objectively investigate whether the lymph fluid added to the circulation through Complex Decongestive Physiotherapy in lymphedema patients has an effect on fluid excretion from the body.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group
Complex DecongestivePhysiotherapy program was planned for the affected extremity of the cases. The treatment was performed 5 days a week, for 4 weeks, for a total of 20 sessions and each session was 60 minutes. The treatment included Manual Lymph Drainage, skin care, multi-layer bandaging, exercise and compression stockings.
Complex Decongestive Therapy
1. Manual Lymph Drainage: Cervical region lymph drainage and abdominal region lymph drainage (especially combined with abdominal breathing) were applied.
2. Skin Care: Moisturizing creams with a pH of 5.5 were applied to the extremities before bandaging.
3. Multilayer Bandaging: Short pull bandage application was applied in a gradient manner.
4. Exercise: Joint range of motion exercises, breathing exercises (abdominal breathing), decongestive exercises, and self-drainage techniques were taught.
5. Compression Stocking: After the decongestion phase was over, flat knit compression stockings were recommended according to the patient's extremity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complex Decongestive Therapy
1. Manual Lymph Drainage: Cervical region lymph drainage and abdominal region lymph drainage (especially combined with abdominal breathing) were applied.
2. Skin Care: Moisturizing creams with a pH of 5.5 were applied to the extremities before bandaging.
3. Multilayer Bandaging: Short pull bandage application was applied in a gradient manner.
4. Exercise: Joint range of motion exercises, breathing exercises (abdominal breathing), decongestive exercises, and self-drainage techniques were taught.
5. Compression Stocking: After the decongestion phase was over, flat knit compression stockings were recommended according to the patient's extremity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cases diagnosed with lower extremity unilateral/bilateral lymphedema
* Having received or not received radiotherapy and/or chemotherapy
Exclusion Criteria
* Having metastatic disease
* Those diagnosed with severe heart failure and/or arrhythmia
* Arterial disorders
* Kidney diseases
* Infection in affected extremities
* Psychological disorders
* Diabetes
* Nephrotic syndrome
* Diuretic use
* Patients using chemotherapy and drugs that have toxic effects on the kidneys
* Those with liver cirrhosis, liver disease
* Neurological diseases
30 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medipol University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilanur Özkaraoğlu, PT, MSc
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cemile Uydur, MsC
Role: PRINCIPAL_INVESTIGATOR
Avrupa Şafak Hospital Physical Therapy and Rehabilitation Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istanbul Medipol University
Istanbul, Beykoz, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MedipolU-FTR-DO-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.